Research Paper Volume 14, Issue 18 pp 7587—7616
Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer
Figure 7. Impacts of NPS on immunotherapy. (A, B) Associations between NPS and immune response and PFS in advanced non-small cell lung carcinoma patients who receiving immunotherapy. (C–E) Associations between NPS and immune response, OS and PFS in metastatic urothelial cancer patients who receiving immunotherapy. (F) Associations between NPS and PFS in KIRC patients who receiving immunotherapy. (G) Associations between NPS and PFS in urothelium carcinoma patients who receiving immunotherapy.